Bonnie Taft, NP
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 23 years
- Boston University School of Medicine, 2003
Offices
2 locations · University of California San Francisco · UCSF Pediatrics Associates
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Bonnie Taft’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Drugs they prescribed that Part D paid
$1,536,855
Pharmacies billed $1,536,855 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 50) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
17 generic and 33 brand-name prescriptions · $1,536,855 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levocarnitine Sf | 12 | $1,030 | $86 |
Year by year
| 2024 | 50 | None | 0% (0) | 66% | $1,536,855 |
| 2023 | 41 | None | 0% (0) | 71% | $1,934,491 |
| 2022 | 44 | None | 0% (0) | 43% | $668,180 |
| 2021 | 22 | None | 0% (0) | 68% | $300,356 |
| 2020 | 18 | None | 0% (0) | 89% | $939,628 |
| 2017 | 54 | None | 0% (0) | 76% | $93,225 |
| 2016 | 67 | None | 0% (0) | 58% | $195,909 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Lumizyme | 13 | $1,200,657 | $92,358 |
2022: 1 drug
| Levocarnitine Sf | 11 | $1,922 | $175 |
2017: 1 drug
| Proair Hfa | 18 | $1,034 | $57 |
Money from drug and device companies
$2,050 in 2025
| 2025 | 2 | 3 | $2,050 | $2,050 |
| 2024 | 1 | 2 | None | $256 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amicus Therapeutics | Pombiliti | $1,750 | 2 payments
|
| Chiesi USA | Elfabrio | $300 | 1 payment
|
See all 3 published payments
| Amicus Therapeutics | Consulting · 2025-04-02 | Pombiliti | $875 |
| Chiesi USA | Honoraria · 2025-02-21 | Elfabrio | $300 |
| Amicus Therapeutics | Consulting · 2025-02-20 | None | $875 |
See earlier years (2024)
2024: $256
| Genzyme | Cerdelga | $256 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780878132
- Licence
- CA NP17242
- Trained
- Boston University School of Medicine, 2003 · 23 years ago
- Group
- University of California San Francisco · UCSF Pediatrics Associates
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0200X (363LP0200X)
- Mailing address
- 601 4th St, Loft 105, San Francisco, CA, 94107
- NPI first listed
- 2007-08-29
- NPI last updated
- 2009-07-15
This is when the NPI record was last certified, not a medical board exam.